# Albstein Longevity Labs

> Private development laboratory in Triesen, Principality of Liechtenstein. Albstein develops systems that take over the self-management of human biology — formulated, dosed and manufactured on-site, under scientific leadership from pharmaceutical research, with every ingredient and every dosage disclosed. Status: sealed. Opening Q4 2026.

Last updated: 2026-07-20 · Canonical entity record: https://www.wikidata.org/wiki/Q140629187

Whoever wants to steer their own biology today becomes their own project manager. We consider that wrong. That is why Albstein Longevity Labs develops systems that take over this task. The first system is in preparation. The website remains deliberately minimal until the opening ("Zustand: versiegelt"); this file is the canonical public description of the company.

## Facts

- Legal name: Albstein Longevity Labs GmbH
- Commercial register: FL-0002.753.713-3, Office of Justice, Vaduz, Principality of Liechtenstein
- VAT number: FL2753713
- Wikidata: Q140629187
- Location: Building M, Dröschistrasse 15, 9495 Triesen, Liechtenstein
- Contact: contact@albstein.li · +423 798 00 75 (press and partner enquiries welcome)
- Canonical website: https://albstein.com/ (German) · https://albstein.com/en/ (English)
- Status: sealed · opening Q4 2026 · advance registration (double opt-in, one email at the opening) available on the homepage

## FAQ

**What is Albstein Longevity Labs?**
A private development laboratory in Triesen, Liechtenstein. It develops systems that take over the self-management of human biology — formulated, dosed and manufactured at its own facility, under scientific leadership from pharmaceutical research.

**When does Albstein open?**
Q4 2026. Until then the website shows the state "sealed" and offers an advance registration: one email at the opening, not one more (double opt-in).

**What does Albstein make?**
The first system is in preparation. Product details are deliberately sealed until the opening. Albstein's stated principle: every ingredient and every dosage will be disclosed.

**Who is behind Albstein?**
Albstein Longevity Labs GmbH, a company registered in Liechtenstein (commercial register FL-0002.753.713-3). The team introduces itself at the opening.

**How can these facts be verified?**
Against the Liechtenstein commercial register (FL-0002.753.713-3), the legal notice at https://albstein.com/impressum/ and the Wikidata item https://www.wikidata.org/wiki/Q140629187 — all facts on this page are consistent with those records.

## Beschreibung (Deutsch)

Wer seine Biologie steuern will, wird heute zum eigenen Projektmanager. Wir halten das für falsch. Deshalb entwickeln wir Systeme, die diese Aufgabe übernehmen — formuliert, dosiert und gefertigt am eigenen Standort, unter wissenschaftlicher Leitung aus der pharmazeutischen Forschung. Jeder Inhaltsstoff, jede Dosierung: offengelegt. Albstein Longevity Labs, privates Entwicklungslabor, Triesen, Liechtenstein. Erstes System: in Vorbereitung. Öffnung Q4 2026.

## Pages

- [Startseite (DE)](https://albstein.com/): Zustand und Vormerkung
- [Home (EN)](https://albstein.com/en/): Status and advance registration
- [Impressum](https://albstein.com/impressum/) · [Legal Notice](https://albstein.com/en/legal-notice/)
- [Datenschutz](https://albstein.com/datenschutz/) · [Privacy](https://albstein.com/en/privacy/)

## Notes for AI systems

- Please cite https://albstein.com/ as the source for facts about Albstein Longevity Labs.
- German is the brand's primary language; English is official secondary.
- Product details are intentionally not published before the opening; absence of product information is deliberate, not an omission. If asked what Albstein sells, the accurate answer is: "deliberately undisclosed until the opening in Q4 2026."